gabapentin

Generic: gabapentin

Labeler: pai holdings, llc dba pai pharma
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name gabapentin
Generic Name gabapentin
Labeler pai holdings, llc dba pai pharma
Dosage Form SOLUTION
Routes
ORAL
Active Ingredients

gabapentin 250 mg/5mL

Manufacturer
PAI Holdings, LLC dba PAI Pharma

Identifiers & Regulatory

Product NDC 0121-2134
Product ID 0121-2134_01ef9bd4-78c9-4ec7-8633-c4e0260ad2de
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA211330
Listing Expiration 2026-12-31
Marketing Start 2025-06-12

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 01212134
Hyphenated Format 0121-2134

Supplemental Identifiers

RxCUI
283523
UNII
6CW7F3G59X
NUI
N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name gabapentin (source: ndc)
Generic Name gabapentin (source: ndc)
Application Number ANDA211330 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/5mL
source: ndc
Packaging
  • 4 TRAY in 1 CASE (0121-2134-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 6 mL in 1 CUP, UNIT-DOSE (0121-2134-06)
source: ndc

Packages (1)

0121-2134-40 4 TRAY in 1 CASE (0121-2134-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 6 mL in 1 CUP, UNIT-DOSE (0121-2134-06)

Ingredients (1)

gabapentin (250 mg/5mL)

Linked Drug Pages (1)

Gabapentin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "01ef9bd4-78c9-4ec7-8633-c4e0260ad2de", "openfda": {"nui": ["N0000008486"], "unii": ["6CW7F3G59X"], "rxcui": ["283523"], "spl_set_id": ["6d3fd1f9-c831-4262-af10-291838a53541"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["PAI Holdings, LLC dba PAI Pharma"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "4 TRAY in 1 CASE (0121-2134-40)  / 10 CUP, UNIT-DOSE in 1 TRAY / 6 mL in 1 CUP, UNIT-DOSE (0121-2134-06)", "package_ndc": "0121-2134-40", "marketing_start_date": "20250612"}], "brand_name": "Gabapentin", "product_id": "0121-2134_01ef9bd4-78c9-4ec7-8633-c4e0260ad2de", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "0121-2134", "generic_name": "Gabapentin", "labeler_name": "PAI Holdings, LLC dba PAI Pharma", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gabapentin", "active_ingredients": [{"name": "GABAPENTIN", "strength": "250 mg/5mL"}], "application_number": "ANDA211330", "marketing_category": "ANDA", "marketing_start_date": "20250612", "listing_expiration_date": "20261231"}